CDT Equity, Inc. (CDT)
0.91
-0.08
(-8.08%)
USD |
NASDAQ |
Oct 05, 16:00
0.99
+0.08
(+8.79%)
After-Hours: 20:00
CDT Equity Shareholders Equity (Quarterly) : 103.09M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 103.09M |
| March 31, 2026 | 105.45M |
| December 31, 2025 | -7.17M |
| September 30, 2025 | 4.278M |
| June 30, 2025 | 3.529M |
| March 31, 2025 | 3.08M |
| December 31, 2024 | -6.793M |
| September 30, 2024 | -9.118M |
| June 30, 2024 | -5.462M |
| March 31, 2024 | -3.099M |
| Date | Value |
|---|---|
| December 31, 2023 | -0.457M |
| September 30, 2023 | -1.081M |
| June 30, 2023 | 17.04M |
| March 31, 2023 | 17.38M |
| December 31, 2022 | -10.09M |
| September 30, 2022 | 131.91M |
| June 30, 2022 | 131.70M |
| March 31, 2022 | 131.82M |
| December 31, 2021 | 0.0206M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Windtree Therapeutics, Inc. | -11.60M |
| Lifecore Biomedical, Inc. | 16.09M |
| Codexis, Inc. | 32.96M |
| Navidea Biopharmaceuticals, Inc. | -- |
| Biostax Corp. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 126.71M |
| Total Liabilities (Quarterly) | 23.62M |
| Debt to Equity Ratio | 0.0115 |
| Current Ratio | 0.1258 |
| Net Debt Paydown Yield | 9.55% |